Latest Mergers And Acquisitions News

Global Uranium and Enrichment Ltd shares have been suspended from the ASX following Federal Court approval of a scheme of arrangement for acquisition by Snow Lake Resources Ltd.

RPMGlobal Holdings Limited shares will be suspended from the ASX following Federal Court approval of its acquisition by a Caterpillar subsidiary, marking a significant ownership change.

Amcor has reported robust second quarter and half-year results for fiscal 2026, driven by the Berry acquisition and operational synergies. The company reaffirmed its full-year guidance and declared a higher quarterly dividend.

Abacus Group has begun preliminary discussions with Abacus Storage King about potentially internalising its management functions, signaling possible structural changes ahead.

RPMGlobal’s acquisition by Caterpillar has cleared its final legal hurdle, with shares suspended and a $5 per share cash payout set for mid-February.

Pinnacle Investment Management reported an 11% drop in net profit after tax for the first half of FY26, despite record net inflows and a strategic move to fully acquire Pacific Asset Management.

The Federal Court of Australia has approved the acquisition schemes for Global Uranium and Enrichment Limited by Snow Lake Resources, setting the stage for a significant shift in shareholder structure and market listing.

Apiam Animal Health shareholders have overwhelmingly approved the proposed acquisition by Adamantem Capital-controlled entities, clearing a critical hurdle for the $500 million deal.

The Federal Court of Australia has approved Caterpillar’s acquisition of mining software leader RPMGlobal, paving the way for a $5 per share payout to shareholders and a pending ASX trading halt.

Apiam Animal Health shareholders convened on 3 February 2026 to vote on a scheme of arrangement proposing acquisition by Adamantem Capital Fund II, with the board unanimously recommending approval. The scheme offers $0.87 cash per share or scrip alternatives, pending final court approval.

Little Green Pharma Ltd is set to acquire Cannatrek Ltd in a transformative merger that will create one of the largest vertically integrated medicinal cannabis companies globally, with pro-forma FY25 revenue exceeding AUD 112 million.

Xero Limited has outlined a bold AI strategy and detailed the integration of Melio to accelerate its US market growth, supported by new financial disclosures and a clear path to profitability.